Ir al contenido
← Back to search
Award NoticeAwarded

Bupropion HCL ER

DEPT OF DEFENSE · DLA TROOP SUPPORT

This notice records an award. Find active opportunities

Información de Adjudicación

Esta solicitud resultó en una adjudicación a por aproximadamente $23,278,524 el October 6, 2022. Contratos similares son típicamente emitidos por DEPT OF DEFENSE bajo 325412 (Pharmaceutical Preparation Manufacturing).

Número de Adjudicación
SPE2D2-23-D-0002
Monto de Adjudicación
$23,278,524
Fecha de Adjudicación
October 6, 2022

Detalles del Contrato

ID de Aviso
SPE2D2-23-D-0002
Tipo de Oportunidad
Award Notice
Sub-Agencia
DEFENSE LOGISTICS AGENCY
Oficina
DLA TROOP SUPPORT
Fecha de Publicación
Monday, September 14, 2026
Fecha Límite de Respuesta
No especificado
Código PSC
6505
Reserva
Competencia Abierta Completa
Lugar de Desempeño
Hauppauge, NY, 11788, USA
Estado
Awarded

Descripción

Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER

Documents and contact

No public document links were provided with this record.

Check the official notice for attachments and access requirements ↗

Contact
Kyle Lewicki
Email
kyle.lewicki@dla.mil
Phone
4457370977
Loadingchange history…
Loadingrelated notices…